Search
Patexia Community
News and Analysis

Our Members

All »
Arsalan Farrokh
Oleg Vakheta
shimaa osama
R S
Faizan Khan
Linga Murthy Budarapu
parham sameni
Elizebeth Maag
shash sen
dawei wang
Valer Rodak
Genevieve Victoria Kayat
gevorg hmayakyan
Abed dreams
Abhilasha Bora

Innovation, Technology, and IP News

Supreme Court Hears Trademark Dispute Between Whiskey Maker and Dog Toy Manufacturer

Yesterday, the United States Supreme Court heard arguments in a trademark dispute between whiskey maker Jack Daniel's and VIP Products, the manufacturer of a dog toy that parodies...

The Importance of Choosing the Right Attorney for Your Patent Interview

The patent interview process can be a crucial step in obtaining a successful patent application. During the interview, an applicant has the opportunity to clarify issues related to...

FDA Seeks $7.2 Billion Budget for 2024

Written by: Paige L. Cappelli The FDA recently announced that it is seeking a budget of $7.2 Billion for 2024, part of which is intended for “Advancing...

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Apple Inc. v. Vidal, Appeal No. 2022-1249 (Fed. Cir. Mar. 13, 2023) In our Case of the Week, the Federal Circuit allowed Apple’s challenge to the Patent Trial...

A “Known Technique” for Showing a Motivation to Combine References

Written by: Justin J. Gillett & Eric Wittgrove INTEL CORP. V. PACT XPP SCHWEIZ AG Before Newman, Prost, and Hughes. Appeal from the Patent Trial and Appeal Board. Summary...

Feed tagged as "intellectual property law":
FDA Seeks $7.2 Billion Budget for 2024
Knobbe Martens Mar 21, 2023
Written by: Paige L. Cappelli The FDA recently announced that it is seeking a budget of $7.2 Billion for 2024, part of... Read More »
Comment: 1 Favorite (0)
Comments
Allen EhrlichAs an expert in medical devices, the FDA needs additional funding to speed up the timeline for approval of new innovative products. Hoping that Congress will approve this budget.
Mar 21, 2023
A “Known Technique” for Showing a Motivation to Combine References
Knobbe Martens Mar 20, 2023
Written by: Justin J. Gillett & Eric Wittgrove INTEL CORP. V. PACT XPP SCHWEIZ AG Before Newman, Prost, and Hughes. Appeal ... Read More »
Comment: 0 Favorite (0)
Stipulation of Non-Infringement Found Insufficient for Appeal
Knobbe Martens Mar 20, 2023
Written by: Justin J. Gillett & Kenneth O. Aruda, Ph.D. ALTERWAN, INC. V. AMAZON.COM, INC., AMAZON WEB SERVICES, INC. Before... Read More »
Comment: 0 Favorite (0)
Judicial Review Is Available for PTO Director’s Fintiv Rulemaking Procedure
Knobbe Martens Mar 20, 2023
Written by: Justin J. Gillett & David J.K. Hulett APPLE INC. v. VIDAL Before Lourie, Taranto, and Stoll. Appeal from the... Read More »
Comment: 0 Favorite (0)
Health Tracker Systems Alleges Garmin’s Smartwatch Infringes Patents
Knobbe Martens Mar 15, 2023
Written by: Eric Wittgrove Health Tracker Systems LLC (“Health Tracker”) sued Garmin International... Read More »
Comment: 0 Favorite (0)
Women Leading the Way in Intellectual Property: Celebrating Their Contributions on International Women's Day
Mikele Bicolli Mar 8, 2023
International Women's Day is a time to celebrate the contributions and achievements of women across all industries. In the field of... Read More »
Comment: 0 Favorite (0)
Patent on Controlling Access to Drug Delisted From Orange Book
Knobbe Martens Mar 8, 2023
Written by: Nima Zargari, Ph.D. On February 24, 2023, in Jazz Pharms., Inc., v. Avadel CNS Pharms., LLC, the U.S. Court of... Read More »
Comment: 0 Favorite (0)
Using AI to Combat Digital Piracy: Effective Ways to Protect Copyright
Mikele Bicolli Mar 7, 2023
Digital piracy is a serious threat to the intellectual property rights of content creators and businesses. With the rise of the internet... Read More »
Comment: 0 Favorite (0)
Description Prescription
Knobbe Martens Mar 6, 2023
Written by: Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before... Read More »
Comment: 0 Favorite (0)
Patent Directed to System for Controlling Access to Drugs Is Not Listable in the Orange Book
Knobbe Martens Feb 27, 2023
Written by: Tyler S. Cox & Kendall Loebbaka JAZZ PHARMACEUTICALS, INC. v. AVADEL CNS PHARMACEUTICALS, LLC Before Lourie... Read More »
Comment: 0 Favorite (0)
A Leap of Good Faith: When Cries of “They Copied Us” Cannot Be Stopped
Knobbe Martens Feb 22, 2023
Written by: Robert W. Servilio & Jeremy Anapol LINE-NETICS, LLC v. NU TSAI CAPITAL LLC  Before Lourie, Taranto, and... Read More »
Comment: 0 Favorite (0)
Failure to Convert Dismissal Into Summary Judgment Deemed Harmless
Knobbe Martens Feb 22, 2023
Written by: Justin K. Theam & Jeremy Anapol HAWKS TECHNOLOGY SYSTEMS, LLC v. CASTLE RETAIL, LLC Before Reyna, Hughes, and... Read More »
Comment: 0 Favorite (0)
Patexia Insight 169: ITC Section 337 Investigations Continue to Rise
Pedram Sameni Feb 22, 2023
Tomorrow, we will release our fourth annual ITC Intelligence Report, which focuses on the International Trade Commission Section 337 investigations ... Read More »
Comment: 0 Favorite (0)
“Filtering” Appropriate Claim Construction Reasoning
Knobbe Martens Feb 14, 2023
Written by: Emily K. McCorry & Douglas B. Wentzel SSI TECHS., LLC v. DONGGUAN ZHENGYANG ELECTRONIC MECHANICAL LTD. Before... Read More »
Comment: 0 Favorite (0)
Jury Verdict Against Boston Scientific for $42 Million For Infringement of Patent on Biodegradable Drug-Releasing Implant
Knobbe Martens Feb 13, 2023
Written by: Arash Pia On January 31st, 2023, a jury awarded $42 million to medical device company TissueGen in a patent... Read More »
Comment: 0 Favorite (0)
Medical Device Innovations and IP: A Strategy Is Everything
Knobbe Martens Feb 6, 2023
Written by: Kregg Koch & Sabing Lee The original version of this article was published by Life Sciences IP Review. Click here to... Read More »
Comment: 0 Favorite (0)
Supreme Court to Weigh in on Fraud Standard under False Claims Act
Knobbe Martens Jan 30, 2023
Written by: Michael R. Christensen In a move that may substantially increase healthtech companies’ exposure to... Read More »
Comment: 0 Favorite (0)
Patent Affirmed as Unenforceable Due to Prosecution Laches
Knobbe Martens Jan 26, 2023
Written by: Daniel Kiang & Timothy A. Willis PERSONALIZED MEDIA COMMUNICATIONS, LLC V. APPLE INC. Before Reyna... Read More »
Comment: 0 Favorite (0)
BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda
Knobbe Martens Jan 23, 2023
Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »
Comment: 0 Favorite (0)
Potential Sanctions for Alleged Intellectual Property Theft on the Horizon?
Kimberly Hamilton Jan 20, 2023
Background On January 5, 2023, President Biden signed into law S. 1294, the “Protecting American Intellectual Property Act of... Read More »
Comment: 0 Favorite (0)
Show more Newsfeed posts
Menu